Cargando…

Association of mutations in V3/C3 domain with enhanced sensitivity of HIV-1 clade C primary envelopes to autologous broadly neutralizing plasma antibodies

BACKGROUND: Broadly neutralizing antibodies to HIV-1 elicited in infected individuals evolves through shifts in their molecular specificities to viral envelope (Env) in the disease course. Recently, we showed that resistance of circulating HIV-1 clade C to the autologous plasma obtained from one Ind...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deshpande, Suprit, Patil, Shilpa, Kumar, Rajesh, Shrivastava, Tripti, Srikrishnan, Aylur K., Murugavel, Kailapuri G., Koff, Wayne C., Chakrabarti, Bimal K., Bhattacharya, Jayanta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910206/ https://www.ncbi.nlm.nih.gov/pubmed/27307004 http://dx.doi.org/10.1186/s12977-016-0273-x

Ejemplares similares

HIV-1 clade C escapes broadly neutralizing autologous antibodies with N332 glycan specificity by distinct mechanisms
por: Deshpande, Suprit, et al.
Publicado: (2016)

Neutralization diversity of HIV-1 Indian subtype C envelopes obtained from cross sectional and followed up individuals against broadly neutralizing monoclonal antibodies having distinct gp120 specificities
por: Mullick, Ranajoy, et al.
Publicado: (2021)

Elicitation of potent serum neutralizing antibody responses in rabbits by immunization with an HIV-1 clade C trimeric Env derived from an Indian elite neutralizer
por: Kumar, Rajesh, et al.
Publicado: (2021)

Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein
por: Ahmed, Shubbir, et al.
Publicado: (2017)

Characterization of a stable HIV-1 B/C recombinant, soluble, and trimeric envelope glycoprotein (Env) highly resistant to CD4-induced conformational changes
por: Kumar, Rajesh, et al.
Publicado: (2017)

An Efficiently Cleaved HIV-1 Clade C Env Selectively Binds to Neutralizing Antibodies
por: Boliar, Saikat, et al.
Publicado: (2015)

Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity
por: Sutar, Jyoti, et al.
Publicado: (2021)

Membrane bound modified form of clade B Env, JRCSF is suitable for immunogen design as it is efficiently cleaved and displays all the broadly neutralizing epitopes including V2 and C2 domain-dependent conformational epitopes
por: Das, Supratik, et al.
Publicado: (2016)

Cell surface ectodomain integrity of a subset of functional HIV-1 envelopes is dependent on a conserved hydrophilic domain containing region in their C-terminal tail
por: Samal, Sweety, et al.
Publicado: (2018)

The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India
por: Solomon, Sunil S, et al.
Publicado: (2011)

Broad receptor tropism and immunogenicity of a clade 3 sarbecovirus
por: Lee, Jimin, et al.
Publicado: (2023)

Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies
por: Smith, Douglas H., et al.
Publicado: (2010)

Clade-specific variation in susceptibility of Candida auris to broad-spectrum ultraviolet C light (UV-C)
por: Chatterjee, Piyali, et al.
Publicado: (2020)

Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization
por: Ringe, Rajesh, et al.
Publicado: (2012)

Correction: Unique C2V3 Sequence in HIV-1 Envelope Obtained from Broadly Neutralizing Plasma of a Slow Progressing Patient Conferred Enhanced Virus Neutralization
por: Ringe, Rajesh, et al.
Publicado: (2013)

Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India
por: Mehta, Shruti H., et al.
Publicado: (2010)

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
por: Wagh, Kshitij, et al.
Publicado: (2016)

Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection
por: Ringe, Rajesh, et al.
Publicado: (2010)

Structure-guided changes at the V2 apex of HIV-1 clade C trimer enhance elicitation of autologous neutralizing and broad V1V2-scaffold antibodies
por: Sahoo, Anusmita, et al.
Publicado: (2022)

A systematic analysis of a broadly neutralizing antibody AR3C epitopes on Hepatitis C virus E2 envelope glycoprotein and their cross-reactivity
por: Sun, Jing, et al.
Publicado: (2015)

Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
por: Peterhoff, David, et al.
Publicado: (2021)

Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity
por: Augestad, Elias H., et al.
Publicado: (2020)

Global prevalence and molecular characteristics of three clades within hepatitis B virus subgenotype C2: Predominance of the C2(3) clade in South Korea
por: Kim, Dong Hyun, et al.
Publicado: (2023)

Generation and characterization of human monoclonal single chain variable fragments (scFvs) against envelope third variable region (V3) of HIV-1 clade C
por: Kumar, Rajesh, et al.
Publicado: (2012)

Serum Fibrosis Markers for the Diagnosis of Liver Disease Among People With Chronic Hepatitis C in Chennai, India
por: Cepeda, Javier A., et al.
Publicado: (2016)

Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression
por: Tso, For Yue, et al.
Publicado: (2013)

Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
por: Klasse, P. J., et al.
Publicado: (2016)

Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals
por: Cheedarla, Narayanaiah, et al.
Publicado: (2017)

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses
por: Hoffenberg, S, et al.
Publicado: (2012)

HIV-1 envelope accessible surface and polarity: clade, blood, and brain
por: Sowmya, Gopichandran, et al.
Publicado: (2011)

The Patterns of Coevolution in Clade B HIV Envelope's N-Glycosylation Sites
por: Garimalla, Swetha, et al.
Publicado: (2015)

V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques
por: Styles, Tiffany M., et al.
Publicado: (2022)

Phase I Randomised Clinical Trial of an HIV-1(CN54), Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally
por: Lewis, David J., et al.
Publicado: (2011)

Dynamics of Envelope Evolution in Clade C SHIV-Infected Pig-Tailed Macaques during Disease Progression Analyzed by Ultra-Deep Pyrosequencing
por: Tso, For Yue, et al.
Publicado: (2012)

P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes
por: Franti, M, et al.
Publicado: (2009)

Longer sequence insertions in p6 gag play a role in immune escape in HIV-1 subtype C
por: Sharma, Shilpee, et al.
Publicado: (2014)

Association of the infectious bronchitis virus 3c protein with the virion envelope
por: Liu, D.X., et al.
Publicado: (1991)

The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa
por: Sharma, Shilpee, et al.
Publicado: (2017)

Stepwise Conformational Stabilization of a HIV-1 Clade C Consensus Envelope Trimer Immunogen Impacts the Profile of Vaccine-Induced Antibody Responses
por: Hauser, Alexandra, et al.
Publicado: (2021)

High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope
por: Mopuri, Rohini, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s0so303ounbgkgggj72kjbhmth